Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02883673 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
A NA study of Postpartum Hemorrhage, sponsored by Alydia Health.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 15
- Study locations
NCT02883673 is a NA study of Postpartum Hemorrhage that has completed, run by Alydia Health. The registered enrollment target is 107 participants, below the 195-participant average among 11 other Postpartum Hemorrhage trials with a reported enrollment target (45% lower). The trial reports 15 study locations across 11 states.
The verdict
NCT02883673, a NA study of Postpartum Hemorrhage, has completed, sponsored by Alydia Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the Jada System in the control and reduction of primary postpartum hemorrhage.
Conditions Studied
Interventions
- DEVICE Jada System
Study Locations (15)
New York
- New York Presbyterian Queens - Flushing
- Nyph/Cumc - New York
Ohio
- MetroHealth Case Western - Cleveland
- The Ohio State University - Columbus
Pennsylvania
- Geisinger Medical Center - Danville
- UPMC - Magee Women's Hospital - Pittsburgh
Texas
- University of Texas Medical Branch - Galveston
- UT Health Science Center, McGovern School of Medicine - Houston
Alabama
- University of Alabama Birmingham - Birmingham
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Illinois
- Northwestern University - Chicago
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2017-09-17 |
| Est. Completion | 2020-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02883673
The ClinicalTrials.gov registry entry for NCT02883673 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 107 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 195-participant average among 11 other Postpartum Hemorrhage trials with a reported enrollment target (45% lower). The listed sponsor is Alydia Health, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postpartum Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Jada System is the first listed.
NCT02883673 reports 15 study locations spanning 11 distinct geographic areas - top geographies include New York, Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02883673 about?
NCT02883673 is a clinical study titled "Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage". The purpose of this study is to evaluate the safety and effectiveness of the Jada System in the control and reduction of primary postpartum hemorrhage.
What is the current status of trial NCT02883673?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2017-09-17. Estimated completion is 2020-03-25.
What conditions does trial NCT02883673 study?
This clinical trial studies the following conditions: Postpartum Hemorrhage.
What interventions are being tested in trial NCT02883673?
The interventions under investigation include: Jada System (DEVICE).
Who is sponsoring clinical trial NCT02883673?
This trial is sponsored by Alydia Health, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02883673 being conducted?
This trial has 15 study locations across Alabama, District of Columbia, Illinois, Indiana, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Effectiveness of the KOKO Device to Treat Primary Abnormal Postpartum Uterine Bleeding or Hemorrhage
RECRUITING · NA
-
Postpartum Oxytocin Administration in the Era of Delayed Cord Clamping
COMPLETED · NA
-
Active Versus Expectant Management of the Third Stage of Labor
COMPLETED · NA
-
Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
COMPLETED · NA
-
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
RECRUITING · Phase 3
-
Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.